Improving Social Functioning in People With Substance Use and Mental Health Disorders Using VR
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorSykehuset Innlandet HF
About this trial
ROPVR, a multi-centre, pragmatic randomized controlled trial (RCT) aims to evaluate a VR-technology which has been developed within an exploratory study and a development study, which facilitates social functioning among persons with a substance use and mental health disorder. Investigators will test a VR-program versus treatment as usual among patients enrolled into a long-term addiction-treatment facility. The RCT aims to evaluate the effectiveness of VR training compared to treatment as usual in improving resilience, quality of life, practical and social functioning and social participation (from baseline to 6 months), and to evaluate the cost-effectiveness of VR training versus treatment as usual.
Eligibility criteria
Qualifiers
adults aged 18 years or older receiving in-patient SUD treatment in specialized addiction treatment units in South-East Norway. This may include persons serving prison sentences during in-patient treatment according to the Execution of Sentences Act in Norway
having the capability to read, understand and sign the Norwegian informed consent form
willing and able to attend VR training two times a week for 5 weeks
Disqualifiers
significant visual, auditory, or balance impairment or other diseases affecting safety during VR sessions (e.g., epilepsy)
current clinically significant severe mental health disorder (e.g., acute episode of psychosis or current active suicidal plans). Persons with psychotic disorders or other severe mental illness are not excluded if their condition is stable.
severe travel sickness as a proxy for simulation sickness
Trial design
Treatments tested in this trial
- VR training
Treatment groups
102 Participants
are divided into 2 treatment groupsLocations
2Innlandet Hospital Trust2381, Brumunddal Norway
Sykehuset Innlandet HF Hamar Norway
Sponsors and collaborators
Sykehuset Innlandet HF
Lead sponsor
Source ClinicalTrials.gov